Evidence map›Paper›PMID 39057829›Full record

ArticlePathogens (Basel, Switzerland)2024

Manuel Collado-Cuadrado, Claudia Alarcón-Torrecillas, Iván Rodríguez-Escolar, Alfonso Balmori-de la Puente, Elena Infante González-Mohino, Miguel Pericacho, Rodrigo Morchón

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Glyceraldehyde 3-Phosphate Dehydrogenase and Galectin fromAnimals : an open access journal from MDPI · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manuel Collado-CuadradoZoonotic Diseases and One Health Group, Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, Spain.
Claudia Alarcón-TorrecillasBiomedical Research Institute of Salamanca (IBSAL), University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-3878-5248
Iván Rodríguez-EscolarZoonotic Diseases and One Health Group, Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0001-6009-7658
Alfonso Balmori-de la PuenteZoonotic Diseases and One Health Group, Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0001-9070-6709
Elena Infante González-MohinoZoonotic Diseases and One Health Group, Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, Spain.
Miguel PericachoBiomedical Research Institute of Salamanca (IBSAL), University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-0226-482X
Rodrigo MorchónZoonotic Diseases and One Health Group, Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-2699-1482

Funding

General Foundation of University of SalamancaMargarita-Salas as postdoctoral scholarshipUniversity of Salamanca-Banco Santander
6 · The paper itself

Abstract

Heartworm disease caused by

Indexed as

Dirofilaria immitisDirofilariasisEndothelial CellsWolbachiaAnimalsCell ProliferationHumansHuman Umbilical Vein Endothelial CellsVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2FLT1 protein, humanVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2anti-angiogenesisDirofilaria immitisendothelial cellsrWSPWolbachia sp.

Identifiers

PMID39057829
PMCPMC11279419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.